Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVID: PCV20 in Aging PLWH
NCT06514547Phase 4Recruiting
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Jul 2024
- Primary completion
- Sep 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 20 in pneumococcal disease, sponsored by Hennepin Healthcare Research Institute. Started Jul 2024; status: recruiting.
02
Drugs
Prevnar 20
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT06514547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514547.